Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × Saline Solution × Clear all

Phase

Status

Completed 6 Terminated 3 Recruiting 2 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Ovarian Neoplasms 2 Fallopian Tube Neoplasms 2 Stomatitis 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Intraductal Neoplasms 1 Pancreatic Cyst 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Hemorrhage 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1 Advanced Ovarian Cancer 1 Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 27 Cyclophosphamide 17 Nivolumab 16 fludarabine 8 Surveys and Questionnaires 8 Paclitaxel 8 Exercise 8 Doxorubicin 8 Carboplatin 8 Bevacizumab 8 budigalimab 7 atezolizumab 7 Radiotherapy 7 Fluorouracil 7 Docetaxel 7 Dexamethasone 7 Blood Specimen Collection 7 venetoclax 6 lenvatinib 6 cabozantinib 6 Rituximab 6 Prednisone 6 Pemetrexed 6 Oxaliplatin 6 Gemcitabine 6 fludarabine phosphate 5 durvalumab 5 avelumab 5 Vincristine 5 Leucovorin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02261415 2022-10-26

HeLiX

Sunnybrook Health Sciences Centre

Phase 3 Active not recruiting

Hemorrhage, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡